Lawrence A. Reiter

1.3k total citations
32 papers, 697 citations indexed

About

Lawrence A. Reiter is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lawrence A. Reiter has authored 32 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in Lawrence A. Reiter's work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Chemical Synthesis and Analysis (5 papers). Lawrence A. Reiter is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Chemical Synthesis and Analysis (5 papers). Lawrence A. Reiter collaborates with scholars based in United States and Australia. Lawrence A. Reiter's co-authors include John J. Martin, Edward C. Taylor, Brian P. Jones, Peter G. Mitchell, Michael J. Munchhof, Kevin M. Koch, Henry J. Showell, William H. Brissette, Donald M. Engelman and Edward C. Taylor and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and The FASEB Journal.

In The Last Decade

Lawrence A. Reiter

32 papers receiving 661 citations

Peers

Lawrence A. Reiter
Douglas G. Batt United States
Moshe Weitzberg United States
Zaihui Zhang Canada
Shendong Yuan United States
Mary Pat Beavers United States
Robert A. Galemmo United States
Brian W. Fox United Kingdom
Moorthy S. S. Palanki United States
Geeta Patel United Kingdom
Michael R. Michaelides United States
Douglas G. Batt United States
Lawrence A. Reiter
Citations per year, relative to Lawrence A. Reiter Lawrence A. Reiter (= 1×) peers Douglas G. Batt

Countries citing papers authored by Lawrence A. Reiter

Since Specialization
Citations

This map shows the geographic impact of Lawrence A. Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence A. Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence A. Reiter more than expected).

Fields of papers citing papers by Lawrence A. Reiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence A. Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence A. Reiter. The network helps show where Lawrence A. Reiter may publish in the future.

Co-authorship network of co-authors of Lawrence A. Reiter

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence A. Reiter. A scholar is included among the top collaborators of Lawrence A. Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence A. Reiter. Lawrence A. Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duncan, Kenneth W., Nathalie Rioux, P. Ann Boriack‐Sjodin, et al.. (2015). Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666. ACS Medicinal Chemistry Letters. 7(2). 162–166. 103 indexed citations
2.
Shah, Manisha H., D. Huang, Tony Blick, et al.. (2012). An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer. PLoS ONE. 7(1). e29615–e29615. 3 indexed citations
3.
Matthews, Erin, Damien Thévenin, Julia M. Rogers, et al.. (2011). Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation. The FASEB Journal. 25(7). 2234–2244. 55 indexed citations
4.
Brissette, William H., Matthew F. Brown, Jeffrey Casavant, et al.. (2010). Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor. Bioorganic & Medicinal Chemistry Letters. 20(14). 4069–4072. 7 indexed citations
5.
Reiter, Lawrence A., Christopher S. Jones, William H. Brissette, et al.. (2008). Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 18(9). 3000–3006. 10 indexed citations
6.
Reiter, Lawrence A.. (2004). Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1. Bioorganic & Medicinal Chemistry Letters. 2 indexed citations
7.
Reiter, Lawrence A., et al.. (2003). Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3. Bioorganic & Medicinal Chemistry Letters. 13(14). 2331–2336. 27 indexed citations
8.
Reiter, Lawrence A., et al.. (2000). Difluoroketones as inhibitors of matrix metalloprotease-13. Bioorganic & Medicinal Chemistry Letters. 10(14). 1581–1584. 22 indexed citations
9.
Reiter, Lawrence A., James P. Rizzi, Jayvardhan Pandit, et al.. (1999). Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket. Bioorganic & Medicinal Chemistry Letters. 9(2). 127–132. 31 indexed citations
10.
Reiter, Lawrence A., Kevin M. Koch, Anthony D. Piscopio, et al.. (1998). trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor. Bioorganic & Medicinal Chemistry Letters. 8(14). 1781–1786. 11 indexed citations
11.
Showell, Henry J., Maryrose J. Conklyn, Gary P. Hingorani, et al.. (1998). The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543. Journal of Pharmacology and Experimental Therapeutics. 285(3). 946–954. 37 indexed citations
12.
Reiter, Lawrence A. & Brian P. Jones. (1997). Amide-Assisted Hydrolysis of β-Carboxamido-Substituted Phosphinic Acid Esters. The Journal of Organic Chemistry. 62(9). 2808–2812. 25 indexed citations
13.
Robinson, Ralph P., Lawrence A. Reiter, Wayne E. Barth, et al.. (1996). Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole:  Prodrugs for the Enolic OH Group. Journal of Medicinal Chemistry. 39(1). 10–18. 63 indexed citations
14.
Koch, Kevin M., Lawrence S. Melvin, Lawrence A. Reiter, et al.. (1994). (+)-1-(3S,4R)-[3-(4-Phenylbenzyl)-4- hydroxychroman-7-yl]cyclopentane Carboxylic Acid, a Highly Potent, Selective Leukotriene B4 Antagonist with Oral Activity in the Murine Collagen-Induced Arthritis Model. Journal of Medicinal Chemistry. 37(20). 3197–3199. 48 indexed citations
15.
Mitchell, Peter G., Lori Lopresti‐Morrow, Sue A. Yocum, Francis J. Sweeney, & Lawrence A. Reiter. (1994). Inhibition of Interleukin‐1—Stimulated Collagen Degradation in Cartilage Explants. Annals of the New York Academy of Sciences. 732(1). 395–397. 3 indexed citations
16.
Reiter, Lawrence A.. (1994). Peptidic p‐nitroanilide substrates of interleukin‐1β‐converting enzyme. International journal of peptide & protein research. 43(1). 87–96. 14 indexed citations
17.
Reiter, Lawrence A. & John J. Martin. (1993). Interleukin‐1β converting enzyme. International journal of peptide & protein research. 41(5). 476–483. 39 indexed citations
18.
Holt, William F., et al.. (1991). CP-66,948: An antisecretory histamine H2-receptor antagonist with mucosal protective properties. Digestive Diseases and Sciences. 36(12). 1721–1728. 8 indexed citations
19.
LaMattina, John L., et al.. (1990). Antiulcer agents. 4-Substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K+-ATPase. Journal of Medicinal Chemistry. 33(2). 543–552. 20 indexed citations
20.
Reiter, Lawrence A.. (1985). A general synthesis of 4(5)-acylimidazoles from 4-acylaminoisoxazoles.. Tetrahedron Letters. 26(29). 3423–3426. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas G. Batt Breakdown of academic impact, for papers by Moshe Weitzberg Breakdown of academic impact, for papers by Zaihui Zhang Breakdown of academic impact, for papers by Shendong Yuan Breakdown of academic impact, for papers by Mary Pat Beavers Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Brian W. Fox Breakdown of academic impact, for papers by Moorthy S. S. Palanki Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Michael R. Michaelides
Rankless by CCL
2026